Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 187

1.

Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients.

Brown TA, Byrd K, Vreeland TJ, Clifton GT, Jackson DO, Hale DF, Herbert GS, Myers JW, Greene JM, Berry JS, Martin J, Elkas JC, Conrads TP, Darcy KM, Hamilton CA, Maxwel GL, Peoples GE.

Cancer Med. 2019 Jul 5. doi: 10.1002/cam4.2378. [Epub ahead of print]

2.

Thermogenic and psychogenic sweating in humans: Identifying eccrine glandular recruitment patterns from glabrous and non-glabrous skin surfaces.

Schwarck JB, Burdon CA, Taylor EA, Peoples GE, Machado-Moreira CA, Taylor NAS.

J Therm Biol. 2019 May;82:242-251. doi: 10.1016/j.jtherbio.2019.04.017. Epub 2019 Apr 26.

PMID:
31128655
3.

Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial.

Mittendorf EA, Lu B, Melisko M, Price Hiller J, Bondarenko I, Brunt AM, Sergii G, Petrakova K, Peoples GE.

Clin Cancer Res. 2019 Jul 15;25(14):4248-4254. doi: 10.1158/1078-0432.CCR-18-2867. Epub 2019 Apr 29.

PMID:
31036542
4.

Vegetarian-Based Dietary Patterns and their Relation with Inflammatory and Immune Biomarkers: A Systematic Review and Meta-Analysis.

Craddock JC, Neale EP, Peoples GE, Probst YC.

Adv Nutr. 2019 May 1;10(3):433-451. doi: 10.1093/advances/nmy103.

PMID:
30947338
5.

Initial safety analysis of a randomized phase II trial of nelipepimut-S + GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer patients with HER2 low-expressing tumors.

Clifton GT, Peace KM, Holmes JP, Vreeland TJ, Hale DF, Herbert GS, Litton JK, Murthy RK, Lukas J, Peoples GE, Mittendorf Elizabeth A.

Clin Immunol. 2019 Apr;201:48-54. doi: 10.1016/j.clim.2019.02.011. Epub 2019 Feb 25.

PMID:
30817999
6.

Improving the outcomes of checkpoint inhibitors in breast cancer.

Peoples GE.

Lancet Oncol. 2019 Mar;20(3):316-318. doi: 10.1016/S1470-2045(19)30068-3. Epub 2019 Feb 11. No abstract available.

PMID:
30765259
7.

Safety and efficacy of aerobic exercise commenced early after cardiac surgery: A systematic review and meta-analysis.

Doyle MP, Indraratna P, Tardo DT, Peeceeyen SC, Peoples GE.

Eur J Prev Cardiol. 2019 Jan;26(1):36-45. doi: 10.1177/2047487318798924. Epub 2018 Sep 6.

PMID:
30188177
8.

Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence - Implications for vaccine trial design.

Jackson DO, Trappey FA, Clifton GT, Vreeland TJ, Peace KM, Hale DF, Litton JK, Murray JL, Perez SA, Papamichail M, Mittendorf EA, Peoples GE.

Clin Immunol. 2018 Oct;195:28-35. doi: 10.1016/j.clim.2018.06.008. Epub 2018 Jul 17.

PMID:
30025819
9.

Eccentric cycling emphasising a low cardiopulmonary demand increases leg strength equivalent to workload matched concentric cycling in middle age sedentary males.

Lewis MC, Peoples GE, Groeller H, Brown MA.

J Sci Med Sport. 2018 Dec;21(12):1238-1243. doi: 10.1016/j.jsams.2018.05.009. Epub 2018 May 15.

PMID:
29789262
10.

Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors.

Herbert GS, Vreeland TJ, Clifton GT, Greene JM, Jackson DO, Hardin MO, Hale DF, Berry JS, Nichol P, Yin S, Yu X, Wagner TE, Peoples GE.

Vaccine. 2018 May 31;36(23):3247-3253. doi: 10.1016/j.vaccine.2018.04.078. Epub 2018 May 1.

PMID:
29724512
11.

Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response.

Vreeland TJ, Litton JK, Qiao N, Philips AV, Alatrash G, Hale DF, Jackson DO, Peace KM, Greene JM, Berry JS, Clifton GT, Peoples GE, Mittendorf EA.

Clin Immunol. 2018 Jul;192:6-13. doi: 10.1016/j.clim.2018.03.010. Epub 2018 Mar 21.

12.

Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccine.

Hardin MO, Vreeland TJ, Clifton GT, Hale DF, Herbert GS, Greene JM, Jackson DO, Berry JE, Nichols P, Yin S, Yu X, Wagner TE, Peoples GE.

Immunotherapy. 2018 Apr;10(5):373-382. doi: 10.2217/imt-2017-0114.

PMID:
29473470
13.

A vascular mechanism to explain thermally mediated variations in deep-body cooling rates during the immersion of profoundly hyperthermic individuals.

Caldwell JN, van den Heuvel AMJ, Kerry P, Clark MJ, Peoples GE, Taylor NAS.

Exp Physiol. 2018 Apr 1;103(4):512-522. doi: 10.1113/EP086760. Epub 2018 Feb 28.

PMID:
29345019
14.

Routine Pre-Treatment MRI for Breast Cancer in a Single-Payer Medical Center: Effects on Surgical Choices, Timing and Outcomes.

Vreeland TJ, Berry Iv JS, Schneble E, Jackson DO, Herbert GS, Hale DF, Martin JM, Flores M, Pattyn AR, Hata K, Clifton GT, Kirkpatrick AD, Peoples GE.

J Cancer. 2017 Jul 23;8(13):2442-2448. doi: 10.7150/jca.16738. eCollection 2017.

15.

Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells.

Gall VA, Philips AV, Qiao N, Clise-Dwyer K, Perakis AA, Zhang M, Clifton GT, Sukhumalchandra P, Ma Q, Reddy SM, Yu D, Molldrem JJ, Peoples GE, Alatrash G, Mittendorf EA.

Cancer Res. 2017 Oct 1;77(19):5374-5383. doi: 10.1158/0008-5472.CAN-16-2774. Epub 2017 Aug 17.

16.

Evaluation of Attenuated Tumor Antigens and the Implications for Peptide-Based Cancer Vaccine Development.

Berry JS, Vreeland TJ, Hale DF, Jackson DO, Trappey AF, Greene JM, Hardin MO, Herbert GS, Clifton GT, Peoples GE.

J Cancer. 2017 May 11;8(7):1255-1262. doi: 10.7150/jca.16450. eCollection 2017.

17.

Algal supplementation of vegetarian eating patterns improves plasma and serum docosahexaenoic acid concentrations and omega-3 indices: a systematic literature review.

Craddock JC, Neale EP, Probst YC, Peoples GE.

J Hum Nutr Diet. 2017 Dec;30(6):693-699. doi: 10.1111/jhn.12474. Epub 2017 Apr 17. Review.

PMID:
28417511
18.

DHA-rich Fish Oil Increases the Omega-3 Index and Lowers the Oxygen Cost of Physiologically Stressful Cycling in Trained Individuals.

Hingley L, Macartney MJ, Brown MA, McLennan PL, Peoples GE.

Int J Sport Nutr Exerc Metab. 2017 Aug;27(4):335-343. doi: 10.1123/ijsnem.2016-0150. Epub 2017 Mar 24.

PMID:
28338369
19.

Results of a Phase Ib Trial of Combination Immunotherapy with a CD8+ T Cell Eliciting Vaccine and Trastuzumab in Breast Cancer Patients.

Clifton GT, Litton JK, Arrington K, Ponniah S, Ibrahim NK, Gall V, Alatrash G, Peoples GE, Mittendorf EA.

Ann Surg Oncol. 2017 Aug;24(8):2161-2167. doi: 10.1245/s10434-017-5844-0. Epub 2017 Mar 17.

20.

Dietary fish oil delays hypoxic skeletal muscle fatigue and enhances caffeine-stimulated contractile recovery in the rat in vivo hindlimb.

Peoples GE, McLennan PL.

Appl Physiol Nutr Metab. 2017 Jun;42(6):613-620. doi: 10.1139/apnm-2016-0501. Epub 2017 Jan 26.

PMID:
28177707
21.

Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients.

Jackson DO, Byrd K, Vreeland TJ, Hale DF, Herbert GS, Greene JM, Schneble EJ, Berry JS, Trappey AF, Clifton GT, Hardin MO, Martin J, Elkas JC, Conrads TP, Darcy KM, Hamilton CA, Maxwell GL, Peoples GE.

Oncotarget. 2017 Feb 28;8(9):15912-15923. doi: 10.18632/oncotarget.13305.

22.

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence.

Mittendorf EA, Ardavanis A, Litton JK, Shumway NM, Hale DF, Murray JL, Perez SA, Ponniah S, Baxevanis CN, Papamichail M, Peoples GE.

Oncotarget. 2016 Oct 4;7(40):66192-66201. doi: 10.18632/oncotarget.11751.

23.

Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions.

Berry J, Vreeland T, Trappey A, Hale D, Peace K, Tyler J, Walker A, Brown R, Herbert G, Yi F, Jackson D, Clifton G, Peoples GE.

Expert Rev Clin Immunol. 2017 Mar;13(3):235-245. doi: 10.1080/1744666X.2016.1226132. Epub 2016 Aug 30. Review.

PMID:
27552944
24.

Predictive Validity of a Thigh-Worn Accelerometer METs Algorithm in 5- to 12-Year-old Children.

van Loo CM, Okely AD, Batterham M, Hinkley T, Ekelund U, Brage S, Reilly JJ, Peoples GE, Jones R, Janssen X, Cliff DP.

J Phys Act Health. 2016 Jun;13(6 Suppl 1):S78-83. doi: 10.1123/jpah.2015-0721.

25.

Energy Cost of Physical Activities and Sedentary Behaviors in Young Children.

Großek A, van Loo C, Peoples GE, Hagenbuchner M, Jones R, Cliff DP.

J Phys Act Health. 2016 Jun;13(6 Suppl 1):S7-S10. doi: 10.1123/jpah.2015-0720.

PMID:
27392383
26.

Gaining ground on a cure through synergy: combining checkpoint inhibitors with cancer vaccines.

Vreeland TJ, Clifton GT, Herbert GS, Hale DF, Jackson DO, Berry JS, Peoples GE.

Expert Rev Clin Immunol. 2016 Dec;12(12):1347-1357. Epub 2016 Jun 28. Review.

PMID:
27323245
27.

Load carriage, human performance, and employment standards.

Taylor NA, Peoples GE, Petersen SR.

Appl Physiol Nutr Metab. 2016 Jun;41(6 Suppl 2):S131-47. doi: 10.1139/apnm-2015-0486. Review.

28.

Validation of the SenseWear Mini activity monitor in 5-12-year-old children.

van Loo CM, Okely AD, Batterham MJ, Hinkley T, Ekelund U, Brage S, Reilly JJ, Peoples GE, Jones RA, Janssen X, Cliff DP.

J Sci Med Sport. 2017 Jan;20(1):55-59. doi: 10.1016/j.jsams.2016.04.010. Epub 2016 May 6.

29.

Arming the Immune System Through Vaccination to Prevent Cancer Recurrence.

Hale DF, Vreeland TJ, Peoples GE.

Am Soc Clin Oncol Educ Book. 2016;35:e159-67. doi: 10.14694/EDBK_158946. Review.

30.

Clinical Development of the E75 Vaccine in Breast Cancer.

Clifton GT, Gall V, Peoples GE, Mittendorf EA.

Breast Care (Basel). 2016 Apr;11(2):116-21. doi: 10.1159/000446097. Epub 2016 Apr 26. Review.

31.

Injecting Hope--A Review of Breast Cancer Vaccines.

Mittendorf EA, Peoples GE.

Oncology (Williston Park). 2016 May;30(5):475-81, 485. Review.

32.

Peptide-Based Cancer Vaccine Strategies and Clinical Results.

Schneble E, Clifton GT, Hale DF, Peoples GE.

Methods Mol Biol. 2016;1403:797-817. doi: 10.1007/978-1-4939-3387-7_46. Review.

PMID:
27076168
33.

The development and use of the E75 (HER2 369-377) peptide vaccine.

Clifton GT, Peoples GE, Mittendorf EA.

Future Oncol. 2016 Jun;12(11):1321-9. doi: 10.2217/fon-2015-0054. Epub 2016 Apr 5.

34.

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence.

Mittendorf EA, Ardavanis A, Symanowski J, Murray JL, Shumway NM, Litton JK, Hale DF, Perez SA, Anastasopoulou EA, Pistamaltzian NF, Ponniah S, Baxevanis CN, von Hofe E, Papamichail M, Peoples GE.

Ann Oncol. 2016 Jul;27(7):1241-8. doi: 10.1093/annonc/mdw150. Epub 2016 Mar 30.

35.

A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor-dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2.

Greene JM, Schneble EJ, Jackson DO, Hale DF, Vreeland TJ, Flores M, Martin J, Herbert GS, Hardin MO, Yu X, Wagner TE, Peoples GE.

Cancer Immunol Immunother. 2016 Apr;65(4):383-92. doi: 10.1007/s00262-016-1809-6. Epub 2016 Feb 19.

PMID:
26894495
36.

Balancing ballistic protection against physiological strain: evidence from laboratory and field trials.

Taylor NA, Burdon CA, van den Heuvel AM, Fogarty AL, Notley SR, Hunt AP, Billing DC, Drain JR, Silk AJ, Patterson MJ, Peoples GE.

Appl Physiol Nutr Metab. 2016 Feb;41(2):117-24. doi: 10.1139/apnm-2015-0386. Epub 2015 Oct 16.

PMID:
26771198
37.

The effects of thoracic load carriage on maximal ambulatory work tolerance and acceptable work durations.

Peoples GE, Lee DS, Notley SR, Taylor NA.

Eur J Appl Physiol. 2016 Mar;116(3):635-46. doi: 10.1007/s00421-015-3323-5. Epub 2016 Jan 6.

PMID:
26739503
38.

Analysis of Clinical and Pathologic Factors of Pure, Flat Epithelial Atypia on Core Needle Biopsy to Aid in the Decision of Excision or Observation.

Berry JS, Trappey AF, Vreeland TJ, Pattyn AR, Clifton GT, Berry EA, Schneble EJ, Kirkpatrick AD, Saenger JS, Peoples GE.

J Cancer. 2016 Jan 1;7(1):1-6. doi: 10.7150/jca.12781. eCollection 2016.

39.

Vegetarian and Omnivorous Nutrition - Comparing Physical Performance.

Craddock JC, Probst YC, Peoples GE.

Int J Sport Nutr Exerc Metab. 2016 Jun;26(3):212-20. doi: 10.1123/ijsnem.2015-0231. Epub 2015 Nov 16. Review.

PMID:
26568522
40.

Adjuvant HER2/neu peptide cancer vaccines in breast cancer.

Clifton GT, Mittendorf EA, Peoples GE.

Immunotherapy. 2015;7(11):1159-68. doi: 10.2217/imt.15.81. Epub 2015 Nov 16. Review.

PMID:
26567563
41.

Critical issues in cancer vaccine trial design.

Clifton GT, Kohrt HE, Peoples GE.

Vaccine. 2015 Dec 16;33(51):7386-7392. doi: 10.1016/j.vaccine.2015.09.019. Epub 2015 Sep 19. Review.

PMID:
26392010
42.
43.

The utility of heart rate and minute ventilation as predictors of whole-body metabolic rate during occupational simulations involving load carriage.

Notley SR, Peoples GE, Taylor NA.

Ergonomics. 2015;58(10):1671-81. doi: 10.1080/00140139.2015.1026406. Epub 2015 Apr 15.

PMID:
25746518
44.

Novel dendritic cell-based vaccination in late stage melanoma.

Schneble EJ, Yu X, Wagner TE, Peoples GE.

Hum Vaccin Immunother. 2014;10(11):3132-8. doi: 10.4161/hv.29110. Review.

45.

Intrinsic heart rate recovery after dynamic exercise is improved with an increased omega-3 index in healthy males.

Macartney MJ, Hingley L, Brown MA, Peoples GE, McLennan PL.

Br J Nutr. 2014 Dec 28;112(12):1984-92. doi: 10.1017/S0007114514003146. Epub 2014 Oct 30.

PMID:
25355484
46.

Prediction of activity type in preschool children using machine learning techniques.

Hagenbuchner M, Cliff DP, Trost SG, Van Tuc N, Peoples GE.

J Sci Med Sport. 2015 Jul;18(4):426-31. doi: 10.1016/j.jsams.2014.06.003. Epub 2014 Jun 24.

PMID:
25088983
47.

Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients.

Mittendorf EA, Clifton GT, Holmes JP, Schneble E, van Echo D, Ponniah S, Peoples GE.

Ann Oncol. 2014 Sep;25(9):1735-42. doi: 10.1093/annonc/mdu211. Epub 2014 Jun 6.

48.

The HER2 peptide nelipepimut-S (E75) vaccine (NeuVax™) in breast cancer patients at risk for recurrence: correlation of immunologic data with clinical response.

Schneble EJ, Berry JS, Trappey FA, Clifton GT, Ponniah S, Mittendorf E, Peoples GE.

Immunotherapy. 2014;6(5):519-31. doi: 10.2217/imt.14.22. Review.

PMID:
24896623
49.

Time-dependent estimates of recurrence and survival in colon cancer: clinical decision support system tool development for adjuvant therapy and oncological outcome assessment.

Steele SR, Bilchik A, Johnson EK, Nissan A, Peoples GE, Eberhardt JS, Kalina P, Petersen B, Brücher B, Protic M, Avital I, Stojadinovic A.

Am Surg. 2014 May;80(5):441-53.

PMID:
24887722
50.

Future directions for the early detection of recurrent breast cancer.

Schneble EJ, Graham LJ, Shupe MP, Flynt FL, Banks KP, Kirkpatrick AD, Nissan A, Henry L, Stojadinovic A, Shumway NM, Avital I, Peoples GE, Setlik RF.

J Cancer. 2014 Mar 16;5(4):291-300. doi: 10.7150/jca.8017. eCollection 2014. Review.

Supplemental Content

Loading ...
Support Center